Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Announces Full Approval of NEFECON® in Taiwan 2025-08-06 13:09
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics 2025-08-05 21:07
Neopharma Technologies Appoints Exchange Listing to Manage U.S. IPO 2025-08-05 21:00
Sunshine Lake Pharma Co., Ltd. (06887.HK) Completes Listing, Market Capitalisation Expected to Rapidly Surpass RMB 50 Billion 2025-08-05 15:34
Chugai Pharma Taiwan Honored at the AREA 2025 for its Social Empowerment and Green Innovation 2025-08-05 13:02
LA ROCHE-POSAY AND GLOBAL SKIN HEALTH EXPERTS UNITE TO WARN ABOUT LONG TERM CONSEQUENCES OF DANGEROUS 'BURN LINES' SOCIAL MEDIA TREND 2025-08-05 05:15
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease 2025-08-04 14:05
Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE 2025-08-04 09:28
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics 2025-08-04 08:00
First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma's Investigational Antidepressant Targeting NET/DAT/GABAAR 2025-08-03 18:23
Everest Medicines Expands Strategic Investment in I-MAB 2025-08-01 21:02
Norgine welcomes PBS listing in Australia of IFINWIL® (eflornithine) for patients with high-risk neuroblastoma (HRNB) 2025-08-01 06:01
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Received U.S. FDA IND Approval to Initiate a Phase II Clinical Study for Platinum-Resistant Ovarian Cancer 2025-07-31 18:36
Emerald Clinical Trials Confirms CEO Transition and Continuity Plan 2025-07-30 20:00
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company 2025-07-30 20:00
Telix H1 2025 Results: Investor Webcast Notification 2025-07-30 07:00
Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress 2025-07-29 20:00
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ 2025-07-29 10:37
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug 2025-07-28 18:49
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis 2025-07-28 15:20
1 11 12 13 14 15 280